T1	disease_or_phenotypic_feature 89 96	pan-MMP
T2	chemical 97 106	inhibitor
T3	disease_or_phenotypic_feature 250 257	trisomy
T4	disease_or_phenotypic_feature 262 265	CLL
T5	chemical 280 298	idelalisib-treated
T6	disease_or_phenotypic_feature 324 335	sensitivity
T7	chemical 339 349	idelalisib
T8	chemical 427 432	IGF1R
T9	chemical 438 448	idelalisib
T10	chemical 490 503	Nanoparticles
T11	missed_chemical 524 529	Drugs
T12	disease_or_phenotypic_feature 541 552	Blood-Brain
T13	disease_or_phenotypic_feature 584 613	Triple Negative Breast Cancer
T14	disease_or_phenotypic_feature 624 640	Tumor-Associated
T15	chemical 720 727	protein
T16	chemical 759 769	biological
T17	disease_or_phenotypic_feature 852 858	cancer
T18	disease_or_phenotypic_feature 952 967	depression-like
T19	chemical 1033 1041	dopamine
T20	chemical 1079 1082	NAc
T21	chemical 1101 1116	(-)-Epicatechin
T22	corrected_chemical 1101 1128	(-)-Epicatechin metabolites
T23	chemical 1117 1128	metabolites
T24	corrected_disease_or_phenotypic_feature 1237 1268	systemic low-grade inflammation
T25	disease_or_phenotypic_feature 1246 1255	low-grade
T26	disease_or_phenotypic_feature 1351 1360	localized
T27	chemical 1514 1519	metal
T28	disease_or_phenotypic_feature 1626 1632	PE-GDM
T29	chemical 1633 1638	group
T30	disease_or_phenotypic_feature 1681 1692	sensitivity
T31	chemical 1848 1858	Molybdenum
T32	chemical 1929 1934	group
T33	chemical 2024 2032	collagen
T34	disease_or_phenotypic_feature 2054 2071	B-cell lymphoma-2
T35	disease_or_phenotypic_feature 2230 2235	tumor
T36	chemical 2295 2314	antigen-independent
T37	chemical 2407 2414	alcohol
T38	chemical 2449 2456	alcohol
T39	disease_or_phenotypic_feature 2482 2488	Asm-/-
T40	chemical 2610 2621	collagenous
T41	disease_or_phenotypic_feature 2643 2648	tumor
T42	disease_or_phenotypic_feature 2664 2667	HCC
T43	disease_or_phenotypic_feature 2723 2739	oral leukoplakia
T44	disease_or_phenotypic_feature 2749 2772	squamous cell carcinoma
T45	chemical 2784 2787	DNA
T46	disease_or_phenotypic_feature 2917 2923	cancer
T47	missed_chemical 2958 2962	RSL3
T48	chemical 3002 3011	cisplatin
T49	chemical 3095 3117	HDAC inhibitor-induced
T50	disease_or_phenotypic_feature 3161 3174	breast cancer
T51	disease_or_phenotypic_feature 3282 3294	cleft palate
T52	chemical 3319 3328	molecular
T53	chemical 3388 3402	nanostructured
T54	chemical 3403 3417	chitosan-based
T55	chemical 3443 3447	drug
T56	disease_or_phenotypic_feature 3468 3481	periodontitis
T57	chemical 3528 3538	anesthesia
T58	disease_or_phenotypic_feature 3585 3593	acquired
T59	disease_or_phenotypic_feature 3689 3694	tumor
T60	chemical 3785 3795	paclitaxel
T61	missed_chemical 3797 3800	PTX
T62	disease_or_phenotypic_feature 3913 3928	redox-sensitive
R2	treats Arg1:T60 Arg2:T59
R3	treats Arg1:T48 Arg2:T46
R5	treats Arg1:T22 Arg2:T24
R6	treats Arg1:T47 Arg2:T46
R8	treats Arg1:T7 Arg2:T4
R9	treats Arg1:T61 Arg2:T59
T63	corrected_chemical 280 290	idelalisib
R10	treats Arg1:T63 Arg2:T4	
T64	corrected_chemical 3376 3427	Core-sheath nanostructured chitosan-based nonwovens
R1	treats Arg1:T64 Arg2:T56	
T65	corrected_disease_or_phenotypic_feature 564 613	Brain Metastases of Triple Negative Breast Cancer
R11	treats Arg1:T10 Arg2:T65	
R4	treats Arg1:T9 Arg2:T4	
R12	treats Arg1:T11 Arg2:T65	
T66	missed_disease_or_phenotypic_feature 1137 1152	vascular health
R13	causes_or_contributes_to Arg1:T22 Arg2:T66	
R7	treats Arg1:T49 Arg2:T50	
R14	treats Arg1:T55 Arg2:T56	
T67	missed_chemical 3747 3760	PPSP micelles
R15	treats Arg1:T67 Arg2:T59	
T68	missed_chemical 3854 3870;3878 3886	mPEG-PBLA-CC-PTX micelles
R16	treats Arg1:T68 Arg2:T59	
T69	missed_chemical 3872 3876;3878 3886	PPCP micelles
R17	treats Arg1:T69 Arg2:T59	
T70	missed_chemical 3945 3958	PPSP micelles
R18	treats Arg1:T70 Arg2:T59	
